Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

RESPIRATORY SYNCYTIAL VIRUS (RSV) - ANVISA Registration 81246986887

Access comprehensive regulatory information for RESPIRATORY SYNCYTIAL VIRUS (RSV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81246986887 and manufactured by QUIDEL CORPORATION. The registration is held by ORTHO CLINICAL DIAGNÓSTICS DO BRASIL PRODUTOS PARA SAÚDE LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including HANGZHOU ALLTEST BIOTECH CO. LTD, ABBOTT DIAGNOSTICS SCARBOROUGH, INC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
81246986887
Registration Details
ANVISA Registration Number: 81246986887
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Registration Details

81246986887

25351511466202381

21921393000146

Company Information

QUIDEL CORPORATION
United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Sep 04, 2023

VIGENTE

09/18/2025 19:00:01